Reimbursement and Market Access for Pharmaceuticals in Asia

Our regulatory experts will help you procure a competitive drug reimbursement price for your pharmaceutical product in Asia.

To learn more about how we can assist you with reimbursement issues in Asia, contact us now to discuss your specific needs.

Obtaining reimbursement status from the local Asian government and procuring a high reimbursement price is essential for your sales in the Asian markets.

With our extensive knowledge and experience with the reimbursement regulations and procedures in each Asian country, Pacific Bridge Medical can help you acquire a profitable reimbursement price for your drug product in Asia.

How difficult is the process for obtaining reimbursement for pharmaceutical products in Asia?

• In the most developed Asian countries, the government will provide reimbursement for purchased pharmaceutical products.
• In the less advanced countries in Asia, the government generally provides little or no reimbursement. In these cases, some of the burden of payment may fall to the patient or to local charities. However, it is expected that these countries will further develop their reimbursement policies in time.
• If you are unfamiliar with the reimbursement policies and procedures in the Asian countries, the government may attempt to reimburse your drug product at the same price as they reimburse other similar products, even if your product includes additional features or enhanced safety/efficacy. In order to procure a reasonable price, expertise in communicating and negotiating with the local Asian government agencies is essential.

To learn more about how we can assist you with reimbursement issues in Asia, contact us now to discuss your specific needs.

Related Resources

Visit our Resource Center to view free webcasts and charts or read publications, news, and research reports on the Asia medical markets.

Related News Briefs

Visit our Resource Center to view free webcasts and charts or read publications, news, and research reports on the Asia medical markets.